Longitudinal burden of disease in hypertrophic cardiomyopathy: one-year follow-up of the AFFECT-HCM study
Over a one-year follow-up period, the QoL remained stable, while the societal costs decreased in both G+/P- individuals and HCM patients, and a significant reduction in BoD was observed among symptomatic oHCM patients, in particular those classified as NYHA III.